# Dolby Laboratories, Inc. (DLB) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Dolby Laboratories, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/DLB/mda/fy2025/): filed 2025-11-18; accession 0001308547-25-000007 (https://www.sec.gov/Archives/edgar/data/1308547/000130854725000007/dlb-20250926.htm); latest 10-K
- [FY 2024 MD&A](/company/DLB/mda/fy2024/): filed 2024-11-19; accession 0001628280-24-048519 (https://www.sec.gov/Archives/edgar/data/1308547/000162828024048519/dlb-20240927.htm)
- [FY 2023 MD&A](/company/DLB/mda/fy2023/): filed 2023-11-17; accession 0001628280-23-039389 (https://www.sec.gov/Archives/edgar/data/1308547/000162828023039389/dlb-20230929.htm)
- [FY 2022 MD&A](/company/DLB/mda/fy2022/): filed 2022-11-18; accession 0001628280-22-030390 (https://www.sec.gov/Archives/edgar/data/1308547/000162828022030390/dlb-20220930.htm)
- [FY 2021 MD&A](/company/DLB/mda/fy2021/): filed 2021-11-17; accession 0001628280-21-023630 (https://www.sec.gov/Archives/edgar/data/1308547/000162828021023630/dlb-20210924.htm)

Back to /company/DLB/